Skip to content

Welcome to Discover Pharma! Today is : November 5, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    OrganaBio to manufacture RxMP haemostatic therapy RMP-402

    OrganaBio has entered a manufacturing partnership with RxMP Therapeutics to [...]

    June 11, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain

    Cellares raises $277M Series D as ARK Invest backs cell therapy manufacturing

    Cellares has expanded its Series D financing to $277 million [...]

    June 10, 2026
  • Advanced Therapies,Drug Discovery & Development

    Cartesian licenses WestGene platform to advance in vivo CAR-T for autoimmune diseases

    Cartesian Therapeutics has signed a strategic licensing agreement with WestGene [...]

    June 9, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    CuraCell reports pancreatic cancer findings from personalised TIL therapy programme

    CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

    June 8, 2026
  • Advanced Therapies,Drug Discovery & Development,Medical devices

    Crowdhelix launches regenerative medicine network to support bioprinted cornea research

    Crowdhelix has launched a new international innovation network focused on [...]

    June 8, 2026
  • Advanced Therapies,Drug Discovery & Development

    Circio and GenAssist partner on next-generation gene therapies for muscle diseases

    Circio and GenAssist have announced a research collaboration aimed at [...]

    June 6, 2026
  • Advanced Therapies,Digital & Data,Drug Discovery & Development

    Laverock secures £2.2M to advance AI-powered cell therapy platform

    Laverock Therapeutics has secured more than £2.2 million in grant [...]

    June 6, 2026
  • Advanced Therapies,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Skyhawk reports encouraging 12-month Huntington’s disease data for SKY-0515

    Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

    June 6, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema

    Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

    Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

    May 5, 2026
Previous678Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Carterra and AstraZeneca target AI-driven drug discovery
    Categories: Biotech & Pharma Business, Digital & Data, Drug Discovery & Development, Research & Development
  • Biopharma dealmaking outlook improves despite investor caution
    Categories: Biotech & Pharma Business, Research & Development
  • SurVaxM improves survival in Phase 2b glioblastoma trial
    Categories: Central Nervous System, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top